These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33050894)

  • 1. Importance of scientific collaboration in contemporary drug discovery and development: a detailed network analysis.
    Cheng F; Ma Y; Uzzi B; Loscalzo J
    BMC Biol; 2020 Oct; 18(1):138. PubMed ID: 33050894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History and Prospects of Drug Discovery and Development Collaboration between Industry and Academia.
    Singh SB; Martin GE; McKittrick B; Crowther J; Fraenkel H; Lunn C; Bayne M; Perkins JB; Gullo V
    J Nat Prod; 2024 Apr; 87(4):1235-1245. PubMed ID: 38554098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.
    Gromo G; Mann J; Fitzgerald JD
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From scientific discovery to cures: bright stars within a galaxy.
    Williams RS; Lotia S; Holloway AK; Pico AR
    Cell; 2015 Sep; 163(1):21-3. PubMed ID: 26406364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consideration on Academia Environments for Creating Medical Innovation].
    Iida K; Ishida T; Nishimura N
    Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing novel therapies for neurodegeneration through an innovative model for industry-academia collaborations: A decade of the Eisai-UCL experience.
    Atkinson PJ; Swami M; Ridgway N; Roberts M; Kinghorn J; Warner TT; Staddon JM; Takle AK
    Drug Discov Today; 2023 Oct; 28(10):103732. PubMed ID: 37541423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving drug discovery: the fundamental role of academic labs.
    Silber BM
    Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Open Science the Future of Drug Development?
    Shaw DL
    Yale J Biol Med; 2017 Mar; 90(1):147-151. PubMed ID: 28356902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scientific productions in Iranian biomedical ethics: A combined study of bibliometrics and social network analysis.
    Mardani A; Parsapoor A; Asghari F; Shamsi Gooshki E
    Dev World Bioeth; 2022 Sep; 22(3):126-139. PubMed ID: 33438806
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.